Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Shen

Showing results (1-10 of 1,604) with videos related to

Pageof 161
Sort By:
International Journal of Cancer|October 3, 2023
Current status and challenges of gastrointestinal cancer treatment in ChinaLin Shen
Med (New York, N.Y.)|January 11, 2025
Q&A with Lin ShenLin Shen
Innovation (Cambridge (Mass.))|May 10, 2022
Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challengesLin Shen
Cancer Communications (London, England)|December 20, 2018
Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancerLin Shen
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|April 25, 2014
[Interpretation on 2013 updated Chinese Consensus on the Diagnosis and Treatment of Gastrointestinal Stromal Tumors]Lin Shen
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|September 12, 2007
[Chemotherapy and target-therapy of gastrointestinal tumors call for development of pathology]Lin Shen
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|December 9, 2016
[Implementation of multidisciplinary team in the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasm]Panpan Zhang, Lin Shen
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 9, 2008
[Effects of Migu tablet on bone mineral density, serum matrix metalloproteinase-2 level and bone metabolic markers in postmenopausal osteoporosis]Yi Dai, Lin Shen
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|November 26, 2014
[Application of molecular targeted agents in comprehensive treatment of gastrointestinal cancer]Jian Li, Lin Shen
JAMA Oncology|September 4, 2025
Rethinking Platforms in ERBB2-Positive Gastric Cancer-ReplyZhi Peng, Lin Shen
Pageof 161

Showing results (1-10 of 1,604) with videos related to

Sort By:
Pageof 161
International Journal of Cancer|October 3, 2023
Current status and challenges of gastrointestinal cancer treatment in ChinaLin Shen
Med (New York, N.Y.)|January 11, 2025
Q&A with Lin ShenLin Shen
Innovation (Cambridge (Mass.))|May 10, 2022
Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challengesLin Shen
Cancer Communications (London, England)|December 20, 2018
Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancerLin Shen
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|April 25, 2014
[Interpretation on 2013 updated Chinese Consensus on the Diagnosis and Treatment of Gastrointestinal Stromal Tumors]Lin Shen
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|September 12, 2007
[Chemotherapy and target-therapy of gastrointestinal tumors call for development of pathology]Lin Shen
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|December 9, 2016
[Implementation of multidisciplinary team in the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasm]Panpan Zhang, Lin Shen
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 9, 2008
[Effects of Migu tablet on bone mineral density, serum matrix metalloproteinase-2 level and bone metabolic markers in postmenopausal osteoporosis]Yi Dai, Lin Shen
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|November 26, 2014
[Application of molecular targeted agents in comprehensive treatment of gastrointestinal cancer]Jian Li, Lin Shen
JAMA Oncology|September 4, 2025
Rethinking Platforms in ERBB2-Positive Gastric Cancer-ReplyZhi Peng, Lin Shen
Pageof 161